Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new SmartParts™ family of intelligent  transmitters and actuators.  SmartParts are the building blocks for Finesse’s next generation of bioreactor controller systems that are intelligent and universal.  In this context intelligent and universal indicate that they have plug-and-play capability and can control any size or type of upstream vessel.   This reduces complexity and increases efficiency and flexibility for the end user.

Recombumin® Alpha used by MAQUET CARDIOPULMONARY in a version of the company’s proprietary BIOLINE Coating

Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin® Alpha - formerly Albucult®, a recombinant human albumin (rAlbumin) product. Recombumin Alpha is used by MAQUET in a version of the company’s proprietary BIOLINE Coating, which has already received regulatory approval and is being used successfully in many countries around the world. This approval represents yet another landmark registration for Novozymes Biopharma’s Recombumin portfolio and the first for a medical device product in Japan.

Hercules, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products today announced that they have acquired a new cell sorting system from Propel Labs.

Under the terms of agreement, Bio-Rad has acquired an automated, easy-to-use benchtop sorting flow cytometer. The instrument will be offered by Bio-Rad as the S3™ Cell Sorter. First shipments are anticipated in January 2013. Other terms of the agreement were not disclosed.